Neurotoxicodynamics of the interaction between ciprofloxacin and foscarnet in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 691-694

  Matsuo, Hirotami ^a   Ryu, Miwako ^a   Nagata, Aya ^a   Uchida, Takahiro ^a   Kawakami, Jun Ichi ^b   Yamamoto, Koujirou ^b   Iga, Tatsuji ^b   Sawada, Yasufumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; CIPROFLOXACIN; ENOXACIN; FENBUFEN; FOSCARNET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVULSION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG INHIBITION; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0031895280     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.691     Document Type: Article

References (22)

1. Akahane, K., M. Sekiguchi, T. Une, and Y. Osada. 1989. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with γ-aminobutyric acid receptor sites. Antimicrob. Agents Chemother. 33:1704-1708.
2. A receptor in dissociated hippocampal cells of rat. J. Neurophysiol. 66:497-504.
3. Anastasio, G. D., D. Menscer, and J. M. Little, Jr. 1988. Norfloxacin and seizures. Ann. Intern. Med. 109:169-170.
4. Chrisp, P., and S. P. Clissold. 1991. Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 41:104-129.
5. Davey, P. G. 1988. Overview of drug interactions with quinolones. J. Antimicrob. Chemother. 22:97-107.
6. Fan-Harvard, P., V. Sanchorawala, J. Oh, E. M. Moser, and S. P. Smith. 1994. Concurrent use of foscarnet and ciprofloxacin may increase the propensity for seizures. Ann. Pharmacother. 28:869-872.
7. Fernandes, P. B. 1988. Mode of action, and in vitro and in vivo activities of the fluoroquinolones. J. Clin. Pharmacol. 28:156-168.
8. Geiger, J. D., M. E. Johnson, and V. Yago. 1988. Pharmacological characterization of rapidly accumulated adenosine by dissociated brain cells from adult rat. J. Neurochem. 51:283-291.
9. Hori, S., J. Shimada, A. Saito, M. Matsuda, and T. Miyahara. 1989. Comparison of the inhibitory effects of new quinolones on γ-aminobutyric acid receptor binding in the presence of antiinflammatory drugs. Rev. Infect. Dis. 11(Suppl.):S1397-S1398.
10. Ichikawa, N., K. Naora, M. Hayashibara, Y. Katagiri, and K. Iwamoto. 1992. Effect of fenbufen on the entry of new quinolones, norfloxacin and ofloxacin, into the central nervous system in rats. J. Pharm. Pharmacol. 44:915-920.
11. A receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo. Toxicol. Appl. Pharmacol. 145:246-254.
12. Lesher, G. Y., E. J. Froelich, M. D. Gruett, J. H. Bailey, and R. P. Brundage. 1962. 1,8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Pharm. Chem. 5:1063-1065.
13. Lode, H., G. Hoffken, K. Borner, and P. Koeppe. 1989. Unique aspects of quinolone pharmacokinetics. Clin. Pharmacokinet. 16(Suppl.):1-4.
14. Lor, E., and Y. Q. Liu. 1994. Neurologic sequelae associated with foscarnet therapy. Ann. Pharmacother. 28:1035-1037.
15. Malinverni, R., and M. P. Glauser. 1988. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev. Infect. Dis. 16(Suppl.):S153-S163.
16. Naora, K., Y. Katagiri, N. Ichikawa, M. Hayashibara, and K. Iwamoto. 1991. Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen. J. Pharmacol. Exp. Ther. 258:1033-1037.
17. Paton, J. H., and D. S. Reeves. 1991. Clinical features and management of adverse effects of quinolone antibacterials. Drug Saf. 6:8-27.
18. Simpson, K. J., and M. J. Brodie. 1985. Convulsions related to enoxacin. Lancet ii:161.
19. Sogel, F., U. Jaehde, K. Naber, and U. Stephan. 1989. Pharmacokinetic disposition of quinolones in human body fluids and tissues. Clin. Pharmacokinet. 16(Suppl.):5-24.
20. Thys, J.-P. 1988. Quinolones in the treatment of bronchopulmonary infections. Rev. Infect. Dis. 10(Suppl.):S212-S217.
21. Tsuji, A., H. Sato, Y. Kume, I. Tamai, E. Okezaki, O. Nagata, and H. Kato. 1988. Inhibitory effects of quinolone antibacterial agents on γ-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob. Agents Chemother. 32:190-194.
22. Tsuji, A., H. Sato, E. Okezaki, O. Nagata, and H. Kato. 1988. Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of γ-aminobutyric acid binding to rat brain membranes in vitro. Biochem. Pharmacol. 37:4408-4411.